|
|
【LYC 0075 交流专区】(前名 MEXTER)
[复制链接]
|
|
|
发表于 28-10-2018 06:52 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "THE COMPANY")SHAREHOLDER AGREEMENT ENTERED BETWEEN THE COMPANY AND ASIAVEST INVESTMENTS PTE. LTD. AND SUBSCRIPTION OF ADDITIONAL ORDINARY SHARES IN THE SHARE CAPITAL OF LYC SENIOR LIVING SDN BHD | Reference is made to the announcement of the Company on 5 June 2018, in relation to the incorporation of a wholly-owned subsidiary known as LYC Senior Living Sdn Bhd (Company No. 1282603-P) ("LYCSL").
The Board of Directors of MEXTER wishes to announce that the Company had on 26 October 2018 entered into a Shareholder Agreement with Asiavest Investments Pte. Ltd. (Company No. 201822984W) (“Asiavest”) (“Shareholder Agreement”) to formalize and set out the basic terms of their relationship with each other and via their respective investment and participation in the business of LYCSL.
Kindly refer to the attached announcement on the Shareholder Agreement entered between the Company and Asiavest .
This announcement is dated 26 October 2018. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5956173
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-11-2018 06:22 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")PROPOSED DISPOSAL OF 80% EQUITY INTEREST IN MEXCOMM SDN BHD ("MEXCOMM"), A SUBSIDIARY OF MEXTER TO CHAN WAI FONG FOR A CASH CONSIDERATION OF RM187,727.20 ("PROPOSED DISPOSAL") | (For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the earlier announcement(s), where applicable, unless stated otherwise or defined herein.)
Reference is made to the Company’s announcement made on 7 September 2018.
On behalf of the Board of Directors of Mexter, Public Investment Bank Berhad wishes to announce that the Proposed Disposal has been completed on 30 October 2018 upon the completion of all requisite security documents in accordance to the terms of the SPA.
This announcement is dated 30 October 2018. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-11-2018 06:27 AM
|
显示全部楼层
本帖最后由 icy97 于 8-11-2018 04:06 AM 编辑
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")(I) PROPOSED DIVERSIFICATION;(II) PROPOSED CONSULTANCY AND PM AGREEMENT;(III) PROPOSED SHAREHOLDERS AGREEMENT;(IV) PROPOSED AMENDMENT TO THE CONSTITUTION; AND(V) PROPOSED CHANGE OF COMPANY NAME,(COLLECTIVELY REFERRED TO AS THE "PROPOSALS"). | On behalf of the Board of Directors of Mexter (“Board”), Public Investment Bank Berhad (“PIVB”) wishes to announce the following:
(i) proposed diversification of the business of Mexter and its subsidiaries (“Group”) to include the following:
(a) provision of consultancy and project management services for the development, construction and sale of integrated healthcare and wellness development, including but not limited to age proof living, medical tourism hotel and residence, medical and dental centre, physiotherapy and chiropractor, childcare and nursery, and wellness facilities (“Wellness Related Hub”);
(b) healthcare service provider, including but not limited to managing and operating the Wellness Related Hub; and
(c) provision of retirement home and aged care facilities and services,
(collectively referred as “Proposed Diversification”).
(ii) LYC Living Sdn Bhd, a 70% owned subsidiary of Mexter (“LYC Living”) had on 30 October 2018 entered into a conditional consultancy and project management agreement with LYC Venture Sdn Bhd (“Consultancy and PM Agreement”) for the provision of general consultancy, advise and project management to facilitate the construction, sale and development of a piece of ten (10) acres 99 year leasehold land held under and known as H.S.(D) 16194, No. PT 20362, Mukim Bentong, Daerah Bentong, Negeri Pahang into a medical, healthcare related and wellness community provisionally known as LYC Wellness Valley (“Project Services”) (“Proposed Consultancy and PM Agreement”);
(iii) Mexter had on 30 October 2018 entered into a shareholders agreement (“Shareholders Agreement”) with Mr. Soh Hoo Hong, an existing shareholder of LYC Living, to facilitate the provision of the Project Services as well as to govern the relationship between Mexter and Mr. Soh as the shareholders of LYC Living (“Proposed Shareholders Agreement”);
(iv) proposed amendment to the constitution of Mexter (“Constitution”) to facilitate the Proposed Diversification (“Proposed Amendment to the Constitution”); and
(v) proposed change of name from Mexter Technology Berhad to LYC Healthcare Berhad (“Proposed Change of Company Name”), (collectively referred as “Proposals”).
The full text of this announcement pertaining to the Proposals is attached herein.
This announcement is dated 30 October 2018. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5959813
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-11-2018 07:55 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | MEXTER TECHNOLOGY BERHAD ("MEXTER" OR "COMPANY")PROPOSED DISPOSAL OF 80% EQUITY INTEREST IN MEXCOMM SDN BHD ("MEXCOMM"), A SUBSIDIARY OF MEXTER TO CHAN WAI FONG FOR A CASH CONSIDERATION OF RM187,727.20 ("PROPOSED DISPOSAL") - CESSATION OF SUBSIDIARIES OF MEXTER | References are made to the Company’s announcements made on 7 September 2018 and 30 October 2018 in relation to the Proposed Disposal of 80% equity interest in Mexcomm.
The Board of Directors of MEXTER wishes to announce that following the completion of the Proposed Disposal on 30 October 2018, the following companies have ceased to be subsidiaries of Mexter (“Cessation”):- (i) Mexcomm Sdn Bhd (ii) Ezymobile International Sdn Bhd (iii) Mobile Holding Ltd. (iv) Ezy M Holding Ltd. (v) E-G6 Solution (Thailand) Co. Ltd. (vi) P.T. Mexcomm
The above Cessation has no material financial and operational impact on Mexter for the financial year ending 31 March 2019. None of the Directors, substantial shareholders of Mexter or persons connected to them has any interest, direct or indirect, in the Cessation.
This announcement is dated 31 October 2018. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-12-2018 07:14 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2018 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2018 | 30 Sep 2017 | 30 Sep 2018 | 30 Sep 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 5,662 | 4,800 | 10,406 | 9,109 | | 2 | Profit/(loss) before tax | -1,465 | -833 | -3,051 | -1,902 | | 3 | Profit/(loss) for the period | -1,463 | -831 | -3,047 | -1,898 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,588 | -686 | -3,072 | -1,611 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.49 | -0.31 | -1.03 | -0.75 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0800 | 0.0800
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-2-2019 05:23 AM
|
显示全部楼层
MEXTER - CHANGE OF NAME FROM MEXTER TECHNOLOGY BERHAD TO LYC HEALTHCARE BERHAD
Kindly be advised that the aforesaid Company has changed its name to "LYC HEALTHCARE BERHAD​”. As such, the Company's shares will be traded and quoted under the new name with effect from 9.00 a.m., Tuesday, 22 January 2019, as follows: Old Name | Old Stock Short Name
| New Name | New Stock Short Name | MEXTER TECHNOLOGY BERHAD | MEXTER | LYC HEALTHCARE BERHAD | LYC |
The Stock Number remains unchanged.
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-2-2019 03:31 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2018 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2018 | 31 Dec 2017 | 31 Dec 2018 | 31 Dec 2017 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 1,807 | 1,681 | 5,133 | 5,163 | | 2 | Profit/(loss) before tax | -2,200 | -862 | -5,287 | -1,825 | | 3 | Profit/(loss) for the period | -514 | -1,058 | -3,597 | -2,956 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -520 | -999 | -3,628 | -2,610 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.16 | -0.41 | -1.22 | -1.18 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0800 | 0.0800
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 9-6-2019 05:26 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A SUBSIDIARY COMPANY | 1. Introduction Pursuant to Rule 9.19(23) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of LYC wishes to announce that the Company has on 30 April 2019 incorporated a Fifty-One percent (51%) owned subsidiary known as LYC Cosmetic & Aesthetic Sdn Bhd (Company No. 1324708-T) ("LYCCA"). The remaining Forty-Nine percent (49%) shareholding is held by Xing Dao International Pte. Ltd. (Company No. 201801391W)(“Xing Dao”).
2. Information of LYCCA LYCCA was incorporated on 30 April 2019 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCCA as at the date of announcement is Ringgit Malaysia One Hundred Only (RM100.00) comprising One Hundred (100) ordinary shares. LYC holds Fifty-One (51) shares for Ringgit Malaysia Fifty-One only (RM51.00), representing 51% shareholding of LYCCA while Xing Dao holds Forty-Nine (49) shares for Ringgit Malaysia Forty-Nine only (RM49.00), representing 49% shareholding of LYCCA.
The intended principal activities of LYCCA are to carry on the business of cosmetics, personal care, wellness related products and services and medical aesthetic treatment. The current directors of LYCCA are Mr Sui Diong Hoe and Dr Zhao Yingli (“Dr Zhao”).
3. Information of Xing Dao Xing Dao is an exempt private limited company by shares in Singapore and is wholly owned by Dr Zhao. The issued share capital of Xing Dao is Singapore Dollars One Hundred Thousand only (SGD100,000) comprising One Hundred Thousand (100,000) ordinary shares. Dr Zhao is the sole director of Xing Dao.
4. Information of Dr Zhao Dr Zhao is the founder of one of the first private cosmetic and aesthetic medical centres in China, Zhi Yin Cosmetic & Aesthetic Medical Centre, Beijing.
Zhi Yin Cosmetic & Aesthetic Medical Centre is a leading pioneer in cosmetic and aesthetic healthcare industry in China, serving thousands of Chinese patients which have benefited from the well-trained team of cosmetic and aesthetic doctors, led by Dr Zhao.
5. Rationale The Company will look to leverage on Dr Zhao’s extensive track record in the cosmetic and aesthetic field and the Company’s healthcare and marketing expertise to drive the business of LYCCA. The incorporation is also in line with the Company’s plans to further diversify its business in the healthcare space, with a focus on medical tourism.
6. Financial Effect of the Incorporation of LYCCA The incorporation of LYCCA does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2020.
7. Directors’ and Major Shareholders’ Interests None of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYCCA.
This announcement is dated 30 April 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6148445
|
|
|
|
|
|
|
|
|
|
|
|
发表于 9-6-2019 05:26 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD (COMPANY NO. 647673-A)("LYC" OR "THE COMPANY")PROPOSAL TO SET-UP OF A SIXTY-EIGHT (68) BEDROOM POSTPARTUM CARE CENTRE AT AURORA PLACE @ BUKIT JALIL, KUALA LUMPUR ("LYCM BUKIT JALIL CENTRE") | The Board of Directors of the LYC wishes to announce that LYC Mother & Child Centre Sdn Bhd (Company No. 972687-K) (“LYCM”) , a wholly-owned subsidiary of the Company had on 30 April 2019 entered into a Tenancy Agreement with Ho Hup Jaya Sdn Bhd (Company No. 82449-V) (“Ho Hup Jaya”) for the rental of one (1) retail unit lot at Aurora SOVO and three (3) retail unit lots at Ho Hup Tower to set-up a postpartum care centre to serve the surrounding neighborhood.
Kindly refer to the attached announcement on the proposed set up of LYCM Bukit Jalil Centre .
This announcement is dated 30 April 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6148453
|
|
|
|
|
|
|
|
|
|
|
|
发表于 27-6-2019 07:37 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2019 | 31 Mar 2018 | 31 Mar 2019 | 31 Mar 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 2,470 | 1,248 | 7,603 | 6,411 | | 2 | Profit/(loss) before tax | -2,238 | -1,471 | -7,525 | -3,296 | | 3 | Profit/(loss) for the period | -2,300 | -2,514 | -5,897 | -5,470 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,253 | -2,570 | -5,881 | -5,180 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.69 | -1.00 | -1.97 | -2.31 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0700 | 0.0800
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 6-8-2019 04:29 AM
|
显示全部楼层
本帖最后由 icy97 于 10-8-2019 06:23 AM 编辑
lyc保健冀私配筹1040万
https://www.enanyang.my/news/20190810/lyc保健冀私配筹1040万/
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | LYC HEALTHCARE BERHAD ("LYC" OR "COMPANY")PROPOSED PRIVATE PLACEMENT OF UP TO 32,486,400 NEW ORDINARY SHARES IN LYC ("LYC SHARE(S)" OR "SHARE(S)"), REPRESENTING APPROXIMATELY TEN PERCENT (10%) OF THE TOTAL NUMBER OF ISSUED SHARES OF LYC ("PROPOSED PRIVATE PLACEMENT") | On behalf of the Board of Directors of LYC, Alliance Investment Bank Berhad wishes to announce that the Company proposes to undertake the Proposed Private Placement.
Further details of the Proposed Private Placement are set out in the attachment.
This announcement is dated 5 August 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6244773
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-8-2019 07:00 AM
|
显示全部楼层
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | LYC HEALTHCARE BERHAD ("LYC" OR "COMPANY") PROPOSED PRIVATE PLACEMENT OF UP TO 32,486,400 NEW ORDINARY SHARES IN LYC ("LYC SHARE(S)" OR "SHARE(S)"), REPRESENTING APPROXIMATELY TEN PERCENT (10%) OF THE TOTAL NUMBER OF ISSUED SHARES OF LYC ("PROPOSED PRIVATE PLACEMENT") | (Unless otherwise defined, defined terms used in this announcement shall carry the same meanings as defined in the announcement dated 5 August 2019 in relation to the Proposed Private Placement ("Announcement"))
We refer to the Announcement in relation to the Proposed Private Placement.
On behalf of the Board of Directors of LYC, Alliance Investment Bank Berhad wishes to announce additional information in relation to the Proposed Private Placement as set out in the attachment enclosed.
This announcement is dated 14 August 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6252793
|
|
|
|
|
|
|
|
|
|
|
|
发表于 23-8-2019 05:14 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2019 | 30 Jun 2018 | 30 Jun 2019 | 30 Jun 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 2,686 | 4,744 | 2,686 | 4,744 | | 2 | Profit/(loss) before tax | -1,592 | -1,589 | -1,592 | -1,589 | | 3 | Profit/(loss) for the period | -1,590 | -1,587 | -1,590 | -1,587 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,543 | -1,488 | -1,543 | -1,488 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.47 | -0.57 | -0.47 | -0.57 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0700 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 8-10-2019 05:53 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Placement Shares issued pursuant to the Proposed Private Placement | No. of shares issued under this corporate proposal | 8,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.3000 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 332,864,340 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 61,615,404.480 | Listing Date | 25 Sep 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-10-2019 08:24 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD (COMPANY NO. 647673-A)("LYC" OR "THE COMPANY")PROPOSAL TO SET-UP A COSMETIC & AESTHETIC CENTRE AT WISMA LIFE CARE IN JALAN KERINCHI, BANGSAR SOUTH, KUALA LUMPUR ("LYCCA BANGSAR SOUTH CENTRE") | The Board of Directors of LYC wishes to announce that LYC Cosmetic & Aesthetics Sdn Bhd (Company No. 1324708-T)(“LYCCA”), a fifty-one percent (51%) owned subsidiary of the Company, had on 4 October 2019 entered into a Tenancy Agreement with Ong Care Scan Sdn Bhd (Company No. 692430-W) for the rental of one (1) retail unit lot at Wisma Life Care to set-up a cosmetic and aesthetic business to cater for both local and international patients.
Kindly refer to the attached announcement on the proposed set up of LYCCA Bangsar South Centre.
This announcement is dated 4 October 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6302709
|
|
|
|
|
|
|
|
|
|
|
|
发表于 30-1-2020 07:46 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Placement Shares issued pursuant to the Proposed Private Placement | No. of shares issued under this corporate proposal | 4,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.3200 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 336,864,340 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 62,895,404.480 | Listing Date | 20 Nov 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 29-2-2020 08:39 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2019 | 30 Sep 2018 | 30 Sep 2019 | 30 Sep 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 3,053 | 5,662 | 5,739 | 10,406 | | 2 | Profit/(loss) before tax | -2,053 | -1,465 | -3,645 | -3,051 | | 3 | Profit/(loss) for the period | -2,051 | -1,463 | -3,641 | -3,047 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,994 | -1,588 | -3,537 | -3,072 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.61 | -0.49 | -1.09 | -1.03 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0700 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-3-2020 07:04 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A WHOLLY OWNED SUB-SUBSIDIARY | 1. Introduction
The Board of Directors of LYC wishes to announce that LYC Mother & Child Centre Sdn Bhd (Registration No. 201101044567 (972687-K)) (“LYCMC”), a wholly owned subsidiary of the Company, has on 6 December 2019 incorporated a wholly owned subsidiary known as LYC Child Care Centre Sdn Bhd (Registration No. 201901044276 (1353606-P)) ("LYCCCC").
2. Information of LYCCCC
LYCCCC was incorporated on 6 December 2019 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCCCC as at the date of announcement is Ringgit Malaysia One Hundred Only (RM100.00) comprising One Hundred (100) ordinary shares. LYCMC holds One Hundred (100) ordinary shares for Ringgit Malaysia One Hundred only (RM100.00), representing 100% shareholding of LYCCCC.
The intended principal activities of LYCCCC are to carry on the business of child daycare activities.
The current directors of LYCCCC are Mr Sui Diong Hoe and Encik Ahmad Rafique bin Mat Tahir.
3. Rationale
Through the Company’s operations of confinement services in Taman Tun Dr Ismail and Puchong centres, LYC has observed strong demand from its customers for child care services beyond the confinement period of one (1) month. Parents are increasingly growing concerned about the quality child care providers available in the market currently and are more willing to pay for premium prices for reputable service providers. The Company believe that as it have a captive market via the confinement services, more parents are willing to consider the Company’s child care services for children aged two (2) months to two (2) years old. These customers will be more assured of the high quality and standard of care by LYC and will allow the Company to further maximize the lifetime value of its customers. As part of the first phase, LYCCCC will seek to offer the child care services in both the Taman Tun Dr Ismail and Puchong premises for children aged 2 months to 2 years old.
Additionally LYCCCC customers could be potential customers of LYC Family Clinic services, which may generate synergies.
4. Financial Effect of the Incorporation of LYCCCC
The incorporation of LYCCCC does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYCCCC for the financial year ending 31 March 2020.
5. Directors’ and Major Shareholders’ Interests
Mr Sui Diong Hoe is the Managing Director cum Group Chief Executive Officer and Encik Ahmad Rafique bin Mat Tahir is the Group Chief Operating Officer of LYC.
Save as disclosed above, none of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYCCCC.
This announcement is dated 10 December 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 29-3-2020 08:41 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A 50% OWNED COMPANY | 1. Introduction
The Board of Directors of LYC wishes to announce that the Company has on 20 December 2019 incorporated a Fifty percent (50%) owned company known as LYC & Chung Fertility Centre Sdn Bhd (Registration No. 201901045953 (1355283-K)) ("LYCCF"). The remaining Fifty percent (50%) shareholding is held by Dr Chung Chow Cheang (NRIC No. 591104-08-6329)(“Dr Chung”).
2. Information of LYCCF
LYCCF was incorporated on 20 December 2019 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCCF as at the date of announcement is Ringgit Malaysia One Hundred Only (RM100.00) comprising One Hundred (100) ordinary shares. LYC holds Fifty (50) shares for Ringgit Malaysia Fifty only (RM50.00), representing Fifty percent (50%) shareholding of LYCCF while Dr Chung holds Fifty (50) shares for Ringgit Malaysia Fifty only (RM50.00), representing Fifty percent (50%) shareholding of LYCCF.
The intended principal activities of LYCCF are to carry on the business of providing Assisted Reproductive Technology (“ART”) services, In Vitro Fertilisation (“IVF”), specialist consultancy services, obstetrics and gynecological services, and providing relevant laboratory services in connection with investigative procedures and other medical and pharmaceutical services.
The current directors of LYCCF are Mr Sui Diong Hoe and Dr Chung Chow Cheang.
3. Information of Dr. Chung Chow Cheang
Dr Chung is a highly qualified fertility specialist with qualifications from Bachelor of Medicine & Bachelor of Surgery (MBBS)(Malaysia), Member / Fellow of the Royal College of Obstetricians and Gynaecologists (MRCOG and FRCOG UK) and more than 25 years’ experience in the industry.
Dr Chung’s area of specialty includes General Obstetrics & Gynaecology, Gynaecological Disorder & Cancer Screening, Pelvic Floor Disorder, Sexually Transmitted Diseases(STDs), Infertility Comprehensive Diagnostic, Infertility / Assisted Reproductive Technologies, Counseling and Treatment.
Dr Chung was previously a Head of Lembaga Penduduk dan Pembangunan Keluarga Negara (LPPKN) Fertility Unit which is under Kementrian Pembangunan Wanita, Keluarga Dan Masyarakat.
Dr Chung currently operates his own fertility clinic called CC Chung Gynaecology & Assisted Reproduction in Jalan Binjai, PNB Perdana, 50450 Kuala Lumpur.
4. Rationale
The Company will look to leverage on Dr. Chung’s extensive track record in the fertility industry and LYC’s healthcare and marketing expertise to drive the business of LYCCF. The move is also in line with the Company’s plans to further diversify its business in the healthcare space, with a focus on medical tourism.
After China scrapped its one-child policy in October 2015, Malaysian Healthcare Travel Council (“MHTC”) estimates there are around 90 million couples in China looking to conceive a second child. Out of these, 40 million are over 40 years of age, it added.
MHTC noted that fertility and cardiology treatments are among the top five treatments sought after by healthcare travellers to Malaysia, alongside orthopaedics, oncology and aesthetics.
Malaysia IVF rates are comparatively cheaper than the other medical tourism countries such as Singapore. This is a potential selling factor which can be tapped on to attract customers. Based on Malaysia’s Budget 2020, Malaysian couples looking to try IVF may withdraw from their Employees Provident Fund (“EPF”) to fund the procedure. Income tax relief of up to RM6,000 given on expenses incurred for medical treatment of serious illnesses will be expanded to include expenses incurred on fertility treatment.
Additionally LYCCF customers could be potential customers of LYC Mother & Child Centre’s confinement services, which may generate synergies.
5. Financial Effect of the Incorporation of LYCCF
The incorporation of LYCCF does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2020.
6. Directors’ and Major Shareholders’ Interests
Mr Sui Diong Hoe is the Managing Director cum Group Chief Executive Officer of LYC.
Save as disclosed above, none of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYCCF.
This announcement is dated 20 December 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-4-2020 08:10 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | LYC HEALTHCARE BERHAD ("LYC" OR THE "COMPANY") - INCORPORATION OF A 51% OWNED SUBSIDIARY | 1. Introduction
The Board of Directors of LYC wishes to announce that the Company has on 27 December 2019 incorporated a Fifty-One percent (51%) owned subsidiary known as LYC Osteoporosis & Chronic Disease Sdn Bhd (Registration No. 201901046531 (1355861-H)) ("LYCOCD"). The remaining Forty-Nine percent (49%) shareholding is held by Dr. Ting Choon Meng (Republic of Singapore Identity Card No. S1345465E)(“Dr. Ting”).
2. Information of LYCOCD
LYCOCD was incorporated on 27 December 2019 as a private limited company by shares in Malaysia under the Companies Act, 2016. The share capital of LYCOCD as at the date of announcement is Ringgit Malaysia One Hundred Only (RM100.00) comprising One Hundred (100) ordinary shares. LYC holds Fifty-One (51) shares for Ringgit Malaysia Fifty One only (RM51.00), representing Fifty-One percent (51%) shareholding of LYCOCD while Dr. Ting holds Forty-Nine (49) shares for Ringgit Malaysia Forty-Nine only (RM49.00), representing Forty-Nine percent (49%) shareholding of LYCOCD.
The intended principal activities of LYCOCD are to carry on the business of providing osteoporosis medical services, chronic medical services, specialist consultancy services and other medical and pharmaceutical services.
The current directors of LYCOCD are Mr Sui Diong Hoe, Dr. Ting Choon Meng and Dr. Tan Su-Lin.
3. Information of Dr. Ting Choon Meng
Dr. Ting specializes in treatment of patients primarily for chronic illnesses for over 30 years. Dr. Ting is a medical doctor, serial inventor of medical devices and an author. He is in private practice in Singapore for more than 20 years.
He is also the inventor of the BPro which is the first wrist-worn device capable of capturing 24 hour blood pressure readings and pulse waveform analysis both at the same time. This patented invention which is Food and Drug Administration (FDA) approved has won awards from World Economic Forum and Frost & Sullivan as Monitoring Technology of the year 2007. BPro is now commercialized in more than 25 countries in the world.
Dr. Ting holds an impressive record in medicine for having treated the most osteo-arthritic - or worn out - knees with viscosupplementation ("VSP") in the world. He has treated over 25,000 knees since he discovered VSP in 1991.
Dr. Ting currently owns and operates T&T Family Health Clinic & Surgery located at 181 Kitchener Road #01-36/38, Parkroyal Hotel Shopping Arcade.
4. Rationale
The Company will look to leverage on Dr. Ting’s extensive track record in the osteoporosis and chronic disease industry and LYC’s healthcare and marketing expertise to drive the business of LYCOCD. The move is also in line with the Company’s plans to further diversify its business in the healthcare space, with a focus on medical tourism.
According to World Health Organization, in Malaysia, chronic diseases accounted for 71% of all deaths in 2002, which represents 85,000 out of 119,000 deaths in that year.
A Health and Morbidity Survey in 2015 found that 47.7% of Malaysians had high cholesterol levels while 17.7% were deemed obese. Non-communicable chronic diseases such as diabetes, hypertension and hyperlipidemia (high cholesterol levels) among Malaysians above 18 is very high.
With an increasingly ageing population and improving income levels, more people are exposed chronic diseases and will seek the kind of services to be provided by LYCOCD.
5. Financial Effect of the Incorporation of LYCOCD
The incorporation of LYCOCD does not have any effect on the share capital and substantial shareholders’ shareholdings of LYC. It is also not expected to have any material effect on the net assets, gearing and earnings of LYC for the financial year ending 31 March 2020.
6. Directors’ and Major Shareholders’ Interests
Mr Sui Diong Hoe is the Managing Director cum Group Chief Executive Officer of LYC.
Save as disclosed above, none of the Directors and/or major shareholders of LYC or persons connected with them, have any direct or indirect interest in the incorporation of LYCOCD.
This announcement is dated 27 December 2019.
|
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
2220 
46
